Indian pharma into the Swiss gateway
India is the pharmacy of the world; Switzerland is Europe's life-sciences heart. We help Indian generics, nutraceuticals and API makers bridge the two - carefully and compliantly.
A natural but demanding fit
Indian manufacturers supply a huge share of the world's generic medicines and active ingredients. Switzerland - home to global pharma and a dense cluster of distributors, CDMOs and clinics - is a demanding but high-value entry point into Europe. The opportunity is real; so is the regulatory bar.
Compliance is the whole game
Swissmedic registration, GMP evidence, documentation and pharmacovigilance are non-negotiable, and requirements differ sharply between prescription drugs, OTC, medical devices and nutraceuticals. We help you understand which pathway applies, connect you with the right local partners, and represent you to Swiss distributors and buyers.
How we de-risk your entry
Regulatory pathway mapping
We clarify whether Swissmedic, medical-device or food-supplement rules apply to your product, and what each demands.
Local partner & CDMO links
Introductions to Swiss distributors, importers and contract partners who fit your product and volume.
Documentation readiness
We help you assemble the GMP, quality and origin documentation Swiss counterparts will expect to see.
Credible local representation
An on-the-ground presence and address so serious Swiss buyers engage with you as a local counterpart.
Questions, answered
Do you handle Swissmedic registration for us?+
We are your market-entry operator, not a regulatory filing house. We map the pathway, prepare you for what is required, and connect you with the specialist regulatory and legal partners who file - then represent you commercially in the market.
We make nutraceuticals, not drugs. Still relevant?+
Very. Supplements and nutraceuticals follow a different, often lighter, food-law pathway in Switzerland, and Swiss consumers spend heavily on wellness. It is frequently a faster first entry than prescription pharma.
Can Switzerland be a gateway to the wider EU?+
It is a strong reference market and cluster, though Switzerland is not in the EU, so EU registrations are separate. We are honest about where a Swiss foothold helps and where you will need parallel EU steps.
What is the smallest sensible first step?+
A market and regulatory feasibility check on one product line, plus a Swiss presence. That tells you whether the numbers work before you invest in registration and inventory.
Explore the Swiss pharma opportunity
Bring us one product line. We will assess the market and regulatory fit before you spend on registration.